Cost-Effectiveness Study of Antimalarial Drug Combinations in Tanzania
Author Information
Author(s): Virginia Wiseman, Michelle Kim, Theonest K Mutabingwa, Christopher J M Whitty
Primary Institution: London School of Hygiene and Tropical Medicine
Hypothesis
How do different combinations of antimalarial drugs compare in terms of cost-effectiveness for treating malaria in Tanzanian children?
Conclusion
Artemether-lumefantrine and amodiaquine with artesunate are the most cost-effective treatments for malaria in Tanzania despite their higher costs.
Supporting Evidence
- Artemether-lumefantrine averted 382 cases of malaria by day 28.
- Amodiaquine with artesunate was also found to be cost-effective.
- Cost savings were higher at day 14 compared to day 28.
- Accuracy of diagnosis significantly influenced treatment effectiveness.
- Indirect costs to families were the largest component of program costs.
Takeaway
This study found that using a combination of certain malaria drugs can save money and help more kids get better, even if those drugs cost more upfront.
Methodology
The study was a randomized effectiveness trial comparing four antimalarial drug combinations in Tanzanian children with malaria.
Potential Biases
Potential biases in diagnosis accuracy could affect the cost-effectiveness results.
Limitations
The findings may not apply to regions with different drug resistance patterns or diagnostic capabilities.
Participant Demographics
Children under the age of 5 diagnosed with non-severe, slide-proven malaria.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website